ORIGINAL PAPERS

   BREAST CANCER

Lapatinib-Associated Toxicity and Practical Management Recommendations

Beverly Moy, Paul E. Goss
The Oncologist 2007; 12: 756-765; doi:10.1634/theoncologist.12-7-756
[Abstract] [Full Text] [PDF]  

Central Nervous System Metastases in HER-2–Positive Metastatic Breast Cancer Patients Treated with Trastuzumab: Incidence, Survival, and Risk Factors

Stefania Gori, Simonetta Rimondini, Verena De Angelis, Mariantonietta Colozza, Giancarlo Bisagni, Gabriella Moretti, Angelo Sidoni, Carlo Basurto, Cynthia Aristei, Paola Anastasi, Lucio Crinò
The Oncologist 2007; 12: 766-773; doi:10.1634/theoncologist.12-7-766
[Abstract] [Full Text] [PDF]  

Fulvestrant (Faslodex®)—How to Make a Good Drug Better

John F. R. Robertson
The Oncologist 2007; 12: 774-784; doi:10.1634/theoncologist.12-7-774
[Abstract] [Full Text] [PDF]  

First-Line Treatment Options for Patients with HER-2–Negative Metastatic Breast Cancer: The Impact of Modern Adjuvant Chemotherapy

Sunil Verma, Mark Clemons
The Oncologist 2007; 12: 785-797; doi:10.1634/theoncologist.12-7-785
[Abstract] [Full Text] [PDF]  

Some Aspects of the Endocrine Profile and Management of Hormone-Dependent Male Breast Cancer

Nikolay V. Dimitrov, Philomena Colucci, Sunil Nagpal
The Oncologist 2007; 12: 798-807; doi:10.1634/theoncologist.12-7-798
[Abstract] [Full Text] [PDF]  

Commentary: A Case for Minimizing Folate Supplementation in Clinical Regimens with Pemetrexed Based on the Marked Sensitivity of the Drug to Folate Availability

Shrikanta Chattopadhyay, Roni Tamari, Sang H. Min, Rongbao Zhao, Eugenia Tsai, I. David Goldman
The Oncologist 2007; 12: 808-815; doi:10.1634/theoncologist.12-7-808
[Abstract] [Full Text] [PDF]  

Delays in Cancer Diagnosis in Underinsured Young Adults and Older Adolescents

Sean Martin, Corinne Ulrich, Mark Munsell, Sarah Taylor, Georgia Lange, Archie Bleyer
The Oncologist 2007; 12: 816-824; doi:10.1634/theoncologist.12-7-816
[Abstract] [Full Text] [PDF]  

Presurgical Chemotherapy in Patients Being Considered for Liver Resection

Nancy Kemeny
The Oncologist 2007; 12: 825-839; doi:10.1634/theoncologist.12-7-825
[Abstract] [Full Text] [PDF]  

Erlotinib in Non-Small Cell Lung Cancer Treatment: Current Status and Future Development

Cesare Gridelli, Maria Anna Bareschino, Clorinda Schettino, Antonio Rossi, Paolo Maione, Fortunato Ciardiello
The Oncologist 2007; 12: 840-849; doi:10.1634/theoncologist.12-7-840
[Abstract] [Full Text] [PDF]  

Multidisciplinary Treatment of Malignant Pleural Mesothelioma

Giovanni Luca Ceresoli, Cesare Gridelli, Armando Santoro
The Oncologist 2007; 12: 850-863; doi:10.1634/theoncologist.12-7-850
[Abstract] [Full Text] [PDF]  

Review: Anti–CTLA-4 Antibody Ipilimumab: Case Studies of Clinical Response and Immune-Related Adverse Events

Jeffrey Weber
The Oncologist 2007; 12: 864-872; doi:10.1634/theoncologist.12-7-864
[Abstract] [Full Text] [PDF]  

Tremelimumab (CP-675,206), a Cytotoxic T Lymphocyte–Associated Antigen 4 Blocking Monoclonal Antibody in Clinical Development for Patients with Cancer

Antoni Ribas, Douglas C. Hanson, Dennis A. Noe, Robert Millham, Deborah J. Guyot, Steven H. Bernstein, Paul C. Canniff, Amarnath Sharma, Jesus Gomez-Navarro
The Oncologist 2007; 12: 873-883; doi:10.1634/theoncologist.12-7-873
[Abstract] [Full Text] [PDF]  

Multidisciplinary Management of Brain Metastases

April F. Eichler, Jay S. Loeffler
The Oncologist 2007; 12: 884-898; doi:10.1634/theoncologist.12-7-884
[Abstract] [Full Text] [PDF]  

Homage to Joel Siegel

Martin J. Murphy, Jr., Joel Siegel
The Oncologist 2007; 12: 899-901; doi:10.1634/theoncologist.12-7-899
[Full Text] [PDF]  

Reflections

Monica G. Marcu
The Oncologist 2007; 12: 3004-3011; doi:10.1634/theoncologist.12-7-7000
[Full Text] [PDF]  

To review many abstracts, check the boxes to the left of the titles you want, and click the 'Get All Checked Abstract(s)' button.